Riskpilot← Back to searchSign inGet full accessBear Diagnostics AB
ABActiveOrg 5592910656Nämndemansbacken 17Hospital activities · NACE 8610Est. 20201 employees
Revenue 2025
SEK 140K
+14% vs 2024
EBITDA margin
77.4%
+29% vs 2024
Equity ratio
55.6%
Financial strength
Net profit 2025
SEK 82K
+35% vs 2024
| Revenue | SEK 140K | +14% |
| EBITDA | SEK 109K | +29% |
| Net profit | SEK 82K | +35% |
| Total assets | SEK 323K | +57% |
| Equity | SEK 180K | +4% |
| Employees | 1 | — |
Legal name
Bear Diagnostics AB
Org number
5592910656
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
16 december 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultation och tjänster inom radiologi, andra områden inom hälso- och sjukvård och därmed förenlig verksamhet.
Address
Nämndemansbacken 17
Email
bjorn.wertman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 135 | 268 | 362 | 123 | 140 |
| Staff expenses | — | — | — | — | −7 |
| EBITDA | 126 | 203 | 302 | 84 | 109 |
| Depreciation & amort. | −0 | −0 | −4 | −4 | −4 |
| EBIT | 126 | 203 | 298 | 80 | 104 |
| Net financials | — | — | 1 | −3 | −1 |
| Profit before tax | 126 | 203 | 299 | 77 | 104 |
| Tax | −27 | −42 | −62 | −16 | −22 |
| Net profit | 99 | 161 | 237 | 61 | 82 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 178 | 327 | 421 | 206 | 323 |
| Equity | 124 | 195 | 312 | 172 | 180 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 54 | 132 | 109 | 34 | 143 |
| Total debt | 54 | 132 | 109 | 34 | 143 |
EBITDA margin
77.4%
This company
15.8%
Market median
+390% vs market
20212025
Equity ratio
55.6%
This company
38.2%
Market median
+46% vs market
20212025
Return on equity
45.9%
This company
18.4%
Market median
+149% vs market
20212025
Net profit margin
58.7%
This company
8.1%
Market median
+625% vs market
20212025
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20212025
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bear Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanna Irma Maria Wertman | Deputy Board Member | 0 companies |
| Björn Åke Peter Wertman | Board of Directors | 0 companies |